A large new review published in 2026 offers reassuring news for families and expectant mothers concerned about antidepressant use during pregnancy. Researchers found no strong evidence that taking antidepressants while pregnant increases the risk of autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) in children after accounting for genetic and family-related factors.
The findings come from an extensive analysis involving nearly 650,000 pregnancies exposed to antidepressants and approximately 25 million pregnancies without exposure. The review, published in The Lancet Psychiatry, is one of the most comprehensive investigations into the topic to date.
For years, scientists and healthcare professionals have debated whether antidepressant medications taken during pregnancy could contribute to developmental conditions such as autism or ADHD in children. Earlier observational studies sometimes suggested a possible connection, creating anxiety among pregnant women managing depression and other mental health disorders.
However, the latest evidence review indicates that the medications themselves may not be responsible for the increased risks previously reported.
Researchers initially observed a 35% higher risk of ADHD and a 69% greater likelihood of autism among children exposed to antidepressants during pregnancy. Yet once investigators adjusted for additional influences, including parental mental health history and genetic predisposition, the apparent association disappeared.
This suggests that underlying mental health conditions within families, rather than antidepressant medications, are more likely to explain the increased rates of autism and ADHD seen in some earlier studies.
Depression during pregnancy is a serious medical condition that can affect both mother and baby. Untreated depression may increase the risk of poor prenatal care, sleep problems, anxiety, substance misuse, premature birth, and difficulties after delivery.
Medical experts emphasize that abruptly stopping antidepressants can also pose risks. Women with moderate to severe depression may experience relapse if treatment is discontinued during pregnancy.
According to the study researchers, healthcare decisions during pregnancy should involve careful discussions between patients and doctors. The benefits of continued treatment must be weighed against potential risks associated with untreated mental illness.
The review reinforces the importance of individualized care rather than generalized fear surrounding antidepressant use.
The analysis paid close attention to different categories of antidepressants. Researchers found no significant association between autism or ADHD and selective serotonin reuptake inhibitors (SSRIs), which are among the most commonly prescribed antidepressants worldwide.
SSRIs include medications frequently used to treat depression and anxiety disorders. These drugs are often considered first-line treatments because of their established safety profiles and effectiveness.
Some elevated risks appeared in connection with older antidepressants such as amitriptyline and nortriptyline. However, researchers noted that these medications are commonly prescribed in more severe or treatment-resistant cases of depression.
Because women taking these medications may have more complex mental health conditions, experts believe the severity of illness itself could influence developmental outcomes rather than the drugs alone.
One of the most important findings from the review involved the role of family and genetic factors.
Researchers observed similar developmental risks in children whose fathers used antidepressants, as well as in mothers who took antidepressants before pregnancy but not during it. This pattern strongly suggests that inherited traits and broader family circumstances may contribute more significantly to autism and ADHD than prenatal medication exposure.
Experts also noted that family stress, parenting challenges, and environmental factors may influence child neurodevelopment. Mental health conditions can affect household routines, emotional stability, and caregiving behaviors, all of which may shape developmental outcomes over time.
The study adds to growing evidence that autism and ADHD are highly complex conditions influenced by multiple genetic and environmental factors rather than a single cause.
The findings may help reduce fear and confusion for pregnant women currently taking antidepressants or considering treatment.
Healthcare professionals generally advise against stopping prescription medications suddenly without medical supervision. Discontinuation can trigger withdrawal symptoms and worsen depression or anxiety.
Instead, experts recommend discussing all treatment options with qualified healthcare providers. In some situations, therapy, lifestyle changes, or medication adjustments may be appropriate. In other cases, continuing antidepressants may provide the safest overall outcome for both mother and baby.
Every pregnancy is different, and treatment decisions should be based on personal medical history, symptom severity, and ongoing professional guidance.
This large-scale review highlights the importance of interpreting medical research carefully. Initial associations in scientific studies do not always prove direct causation.
Observational studies can be affected by confounding variables, meaning outside factors may influence results. In this case, family mental health history and genetics appear to explain much of the increased risk previously attributed to antidepressants.
Experts say the new findings could help physicians provide clearer counseling to patients concerned about antidepressant safety during pregnancy.
Mental health treatment remains a critical part of prenatal care, and reducing unnecessary fear may encourage more women to seek help when needed.
The latest research provides encouraging evidence that antidepressant use during pregnancy is unlikely to directly cause autism or ADHD in children. While ongoing research is still important, the current data suggest that genetic predisposition and family mental health factors play a much larger role than medication exposure itself.
For women experiencing depression during pregnancy, the study reinforces the value of informed, individualized medical care rather than avoiding treatment out of fear.
This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Medical decisions during pregnancy should always be made in consultation with a licensed healthcare professional. Individual risk factors and health conditions vary from person to person.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.